Annual Book Value
$27.65 M
$27.52 M-61.97%
30 April 2024
Summary:
PharmaCyte Biotech annual book value is currently $27.65 million, with the most recent change of +$27.52 million (-61.97%) on 30 April 2024. During the last 3 years, it has risen by +$20.97 million (+313.92%). PMCB annual book value is now -69.25% below its all-time high of $89.92 million, reached on 30 April 2022.PMCB Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$47.71 M
+$20.06 M+72.56%
31 July 2024
Summary:
PharmaCyte Biotech quarterly book value is currently $47.71 million, with the most recent change of +$20.06 million (+72.56%) on 31 July 2024. Over the past year, it has increased by +$10.94 million (+29.76%). PMCB quarterly book value is now -48.21% below its all-time high of $92.12 million, reached on 31 October 2021.PMCB Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Book Value Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -62.0% | +29.8% |
3 y3 years | +313.9% | -48.2% |
5 y5 years | +448.6% | +952.1% |
PMCB Book Value High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -69.3% | +313.9% | -48.2% | +72.6% |
5 y | 5 years | -69.3% | +448.6% | -48.2% | +1004.5% |
alltime | all time | -69.3% | +935.5% | -48.2% | +1541.7% |
PharmaCyte Biotech Book Value History
Date | Annual | Quarterly |
---|---|---|
July 2024 | - | $47.71 M(+72.6%) |
Apr 2024 | $27.65 M(-62.0%) | $27.65 M(-11.9%) |
Jan 2024 | - | $31.38 M(-14.7%) |
Oct 2023 | - | $36.77 M(-14.0%) |
July 2023 | - | $42.73 M(-41.2%) |
Apr 2023 | $72.69 M(-19.2%) | $72.69 M(-5.7%) |
Jan 2023 | - | $77.12 M(-4.8%) |
Oct 2022 | - | $81.04 M(-6.1%) |
July 2022 | - | $86.30 M(-4.0%) |
Apr 2022 | $89.92 M(+1246.2%) | $89.92 M(-1.5%) |
Jan 2022 | - | $91.33 M(-0.9%) |
Oct 2021 | - | $92.12 M(+1512.7%) |
July 2021 | - | $5.71 M(-14.5%) |
Apr 2021 | $6.68 M(+31.3%) | $6.68 M(-12.3%) |
Jan 2021 | - | $7.61 M(-8.0%) |
Oct 2020 | - | $8.28 M(+32.5%) |
July 2020 | - | $6.25 M(+22.7%) |
Apr 2020 | $5.09 M(+1.0%) | $5.09 M(+17.8%) |
Jan 2020 | - | $4.32 M(-4.7%) |
Oct 2019 | - | $4.53 M(-9.3%) |
July 2019 | - | $5.00 M(-0.8%) |
Apr 2019 | $5.04 M(-12.6%) | $5.04 M(-6.1%) |
Jan 2019 | - | $5.37 M(-0.7%) |
Oct 2018 | - | $5.40 M(-12.8%) |
July 2018 | - | $6.20 M(+7.4%) |
Apr 2018 | $5.77 M(-28.7%) | $5.77 M(-1.2%) |
Jan 2018 | - | $5.84 M(-20.6%) |
Oct 2017 | - | $7.35 M(-15.1%) |
July 2017 | - | $8.66 M(+7.1%) |
Apr 2017 | $8.09 M(+24.0%) | $8.09 M(+14.9%) |
Jan 2017 | - | $7.04 M(+12.0%) |
Oct 2016 | - | $6.28 M(-11.1%) |
July 2016 | - | $7.07 M(+8.3%) |
Apr 2016 | $6.52 M(-16.1%) | $6.52 M(-6.0%) |
Jan 2016 | - | $6.94 M(+5.7%) |
Oct 2015 | - | $6.56 M(-5.7%) |
July 2015 | - | $6.96 M(-10.6%) |
Apr 2015 | $7.78 M(-13.0%) | $7.78 M(+24.5%) |
Jan 2015 | - | $6.25 M(-2.1%) |
Oct 2014 | - | $6.38 M(-18.5%) |
July 2014 | - | $7.83 M(-12.5%) |
Apr 2014 | $8.94 M | $8.94 M(+72.5%) |
Jan 2014 | - | $5.18 M(+43.8%) |
Oct 2013 | - | $3.60 M(+89.6%) |
Date | Annual | Quarterly |
---|---|---|
July 2013 | - | $1.90 M(-226.5%) |
Apr 2013 | -$1.50 M(-34.1%) | -$1.50 M(-26.0%) |
Jan 2013 | - | -$2.03 M(-23.0%) |
Oct 2012 | - | -$2.63 M(-10.8%) |
July 2012 | - | -$2.95 M(+29.5%) |
Apr 2012 | -$2.28 M(-31.1%) | -$2.28 M(-19.4%) |
Jan 2012 | - | -$2.83 M(-4.3%) |
Oct 2011 | - | -$2.96 M(-1.0%) |
July 2011 | - | -$2.99 M(-9.8%) |
Apr 2011 | -$3.31 M(+12.1%) | -$3.31 M(+21.7%) |
Jan 2011 | - | -$2.72 M(+3.3%) |
Oct 2010 | - | -$2.63 M(+1.8%) |
July 2010 | - | -$2.59 M(-12.4%) |
Apr 2010 | -$2.95 M(-239.0%) | -$2.95 M(-304.0%) |
Jan 2010 | - | $1.45 M(-51.6%) |
Oct 2009 | - | $2.99 M(-6.2%) |
July 2009 | - | $3.19 M(+50.0%) |
Apr 2009 | $2.12 M(-71.4%) | $2.12 M(-61.7%) |
Jan 2009 | - | $5.55 M(-11.7%) |
Oct 2008 | - | $6.29 M(-9.5%) |
July 2008 | - | $6.95 M(-6.5%) |
Apr 2008 | $7.44 M(+73.5%) | $7.44 M(+75.4%) |
Jan 2008 | - | $4.24 M(+37.4%) |
Oct 2007 | - | $3.09 M(-21.0%) |
July 2007 | - | $3.91 M(-8.9%) |
Apr 2007 | $4.29 M(-2.8%) | $4.29 M(+31.4%) |
Jan 2007 | - | $3.26 M(-7.8%) |
Oct 2006 | - | $3.54 M(-7.3%) |
July 2006 | - | $3.82 M(-13.4%) |
Apr 2006 | $4.41 M(-440.7%) | $4.41 M(-476.4%) |
Jan 2006 | - | -$1.17 M(-28.2%) |
Oct 2005 | - | -$1.63 M(+1.6%) |
July 2005 | - | -$1.61 M(+24.0%) |
Apr 2005 | -$1.30 M(+744.3%) | -$1.30 M(-40.1%) |
Jan 2005 | - | -$2.16 M(+25.9%) |
Oct 2004 | - | -$1.72 M(+234.4%) |
July 2004 | - | -$513.10 K(+234.5%) |
Apr 2004 | -$153.40 K(+6036.0%) | -$153.40 K(-125.2%) |
Jan 2004 | - | $608.60 K(-5.6%) |
Oct 2003 | - | $644.40 K(<-9900.0%) |
July 2003 | - | -$4300.00(+72.0%) |
Apr 2003 | -$2500.00(-68.4%) | -$2500.00(-71.9%) |
Jan 2003 | - | -$8900.00 |
Apr 2002 | -$7900.00 | - |
FAQ
- What is PharmaCyte Biotech annual book value?
- What is the all time high annual book value for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual book value year-on-year change?
- What is PharmaCyte Biotech quarterly book value?
- What is the all time high quarterly book value for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly book value year-on-year change?
What is PharmaCyte Biotech annual book value?
The current annual book value of PMCB is $27.65 M
What is the all time high annual book value for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual book value is $89.92 M
What is PharmaCyte Biotech annual book value year-on-year change?
Over the past year, PMCB annual book value has changed by -$45.04 M (-61.97%)
What is PharmaCyte Biotech quarterly book value?
The current quarterly book value of PMCB is $47.71 M
What is the all time high quarterly book value for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly book value is $92.12 M
What is PharmaCyte Biotech quarterly book value year-on-year change?
Over the past year, PMCB quarterly book value has changed by +$10.94 M (+29.76%)